Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination medical therapy for benign prostatic hyperplasia

H Lepor1

  • 1Department of Urology, New York University School of Medicine, New York, USA.

The Urologic Clinics of North America
|May 1, 1995
PubMed
Summary

Combination therapy using alpha 1 blockade and androgen suppression shows greater efficacy than monotherapies. Ongoing studies will confirm its safety and effectiveness for clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.

Oncogene·2012
Same author

Outcomes of extremely low risk prostate cancer following radical prostatectomy.

Prostate cancer and prostatic diseases·2011
Same author

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.

Prostate cancer and prostatic diseases·2010
Same author

Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.

Clinical pharmacology and therapeutics·2010
Same author

Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.

Prostate cancer and prostatic diseases·2009
Same author

Letter from the editors of reviews in urology.

Reviews in urology·2006

Area of Science:

  • Urology
  • Oncology
  • Pharmacology

Background:

  • Preliminary clinical data suggest combination therapy may be more effective than monotherapy.
  • Alpha 1 blockade and androgen suppression are established treatment modalities.

Purpose of the Study:

  • To evaluate the efficacy and safety of combination therapy versus monotherapy.
  • To determine the optimal role of combination therapy in clinical practice.

Main Methods:

  • Randomized, double-blind, multicenter, placebo-controlled studies are underway.
  • Comparative analysis of combination therapy against individual monotherapies.

Main Results:

  • Preliminary observations indicate superior efficacy for combination therapy.
  • Ongoing studies aim to provide definitive evidence.

Conclusions:

  • Combination therapy shows promise for improved treatment outcomes.
  • Further assessment of efficacy, safety, and cost is required for clinical adoption.

Related Experiment Videos